Cargando…
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
BACKGROUND: Ovarian cancer (OC) is the most fatal gynaecological malignancy and has a poor prognosis. Glycosylation, the biosynthetic process that depends on specific glycosyltransferases (GTs), has recently attracted increasing importance due to the vital role it plays in cancer. In this study, we...
Autores principales: | Xu, Xuyao, Wu, Yue, Jia, Genmei, Zhu, Qiaoying, Li, Dake, Xie, Kaipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826597/ https://www.ncbi.nlm.nih.gov/pubmed/36611197 http://dx.doi.org/10.1186/s13048-022-01088-9 |
Ejemplares similares
-
Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma
por: Sha, Yongliang, et al.
Publicado: (2022) -
Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype
por: Qi, Yiwei, et al.
Publicado: (2023) -
Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022) -
A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
por: Wang, Liang
Publicado: (2021) -
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
por: Fernández, Lara P., et al.
Publicado: (2018)